Get Started

MNOV

NASD MediciNova, Inc.
Nov 2, 2026 · 11:11 AM ET DELAYED Market Open

$1.45 ↑ +0.05 (+3.57%) Trading Up from the previous close of $1.40, $0.08 below the day’s high of $1.53

YTD change
+10.69%
vs 20-day SMA
-1.71%
vs 200-day SMA
-4.24%

Price ranges

Previous day
$1.38 $1.42
open $1.42 close $1.40
-$0.02 (-1.41%)
Today
$1.40 $1.53
open $1.40 now $1.45
+$0.05 (+3.57%)
Past week
$1.38 $1.50
from $1.39 now $1.45
+$0.06 (+4.32%)
Past month
$1.36 $1.89
from $1.78 now $1.45
-$0.33 (-18.54%)
This year
$1.22 $3.90
from $1.31 now $1.45
+$0.14 (+10.69%)

Price & Performance

+0.00 (+0.00%) / 6M

$1.05$1.91$2.77$3.63May 4Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 90.0% away from all-time highs of $14.50
  • MNOV is up 11% since the beginning of the year
  • MNOV is down 13% over the past 12 months
  • MNOV is down 19% over the past 1 month
  • 1% of all MNOV investors are betting against MNOV

MNOV reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -6.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.05
Earnings momentum +20.0% Quarterly EPS growth
Quarterly change +20.0%

Valuation

P/E ratio N/A
Enterprise value $43.6M
Beta 0.82

Balance sheet & scale

IncomeN/A
Revenue$920.5K
Cash$25.4M
Debt$117.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $71.4M

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $927.89 +13.33%
IQV IQVIA Holdings Inc $267.33 -2.81%
CRL Charles River Laboratories International, Inc. $359.41 -4.44%
ICLR ICON Plc $211.36 -1.91%
IT Gartner, Inc. $228.79 +1.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.